Ingredient Evidence Review
Horny Goat Weed in Nitric Boost Ultra
Review of horny goat weed in Nitric Boost Ultra, icariin, PDE5-related mechanisms, human evidence limitations, standardization and safety.
Save or follow this source
Add Male Performance Supplements to Google Preferred Sources or open this page in your preferred AI tool.
Desk ResearchEvidence LabelsSafety ContextUpdated Aug
Published Products
Explore all current MPS evidence-led product reviews.
Botanical evidence
Horny goat weed has interesting preclinical mechanisms but limited robust human outcome data.
Horny goat weed commonly refers to Epimedium species. The compound icariin and related flavonoids have attracted attention because laboratory studies have explored phosphodiesterase-5-related activity and other vascular mechanisms.
That preclinical work is scientifically interesting, particularly because PDE5 is also a pharmacological target in established erectile-dysfunction medicines. But demonstrating enzyme activity in a laboratory setting is not the same as showing that a commercial horny-goat-weed dose produces a clinically meaningful response in men.
For Nitric Boost Ultra, strong human evidence specific to the horny-goat-weed component has not been established from the material reviewed.
Evidence ladder
Where the horny-goat-weed evidence currently sits.
Mechanistic interest
Yes. Icariin and related compounds have been examined for PDE5-related and vascular activity.
Human clinical evidence
Limited. The evidence is not comparable in depth or certainty with approved ED therapies.
Product-specific evidence
Not established. Dose, species, extract and standardization remain important unknowns.
Botanical standardization
The common name does not define the intervention.
Herbal products can differ by species, plant part, extraction method and concentration of marker compounds. “Horny goat weed” on a label does not tell a researcher how much icariin or other relevant compound is present.
A trial using a defined standardized extract would therefore not automatically apply to a different commercial botanical mixture. This is one reason MPS avoids implying that preclinical icariin research proves Nitric Boost Ultra efficacy.
Safety context
Traditional use is not the same as interaction-free use.
Botanicals can have pharmacological activity and can interact with medicines or other supplements. Individual risks depend on dose, health status and co-administered products.
MPS assessment
Preclinical interest: yes. Strong clinical proof for this product: no.
Horny goat weed is a plausible traditional/experimental component, but it should not be used as a shortcut to claim that Nitric Boost Ultra has an established PDE5-like clinical effect.
Horny goat weed evidence map: preclinical mechanism is not human outcome evidence
Horny goat weed is a useful example of why a mechanistic finding should not be treated as equivalent to a clinical result. Icariin-related laboratory work explains scientific interest, but the reviewed material does not establish a robust finished-product effect in men.
| Evidence question | What can be said | What remains uncertain |
|---|---|---|
| Mechanism | Icariin and related compounds have been studied for PDE5-related and vascular activity. | Laboratory activity does not establish a clinically meaningful oral effect. |
| Human evidence | The available human evidence is limited compared with established therapies. | A dependable erectile-function benefit cannot be inferred from preclinical work alone. |
| Preparation identity | Species, plant part, extract and standardization are relevant to product comparison. | The common name “horny goat weed” does not define a research-equivalent intervention. |
| Nitric Boost Ultra | The ingredient can be discussed as part of the formula rationale. | Its presence does not prove the finished product works. |
Interpretation: treat horny goat weed as mechanistically interesting but clinically uncertain unless the exact preparation and outcome evidence are established.
Selected references
Research trail
- PubMed-indexed human/clinical literature: PMID 35958901.
- PubMed-indexed human/clinical literature: PMID 39608617.
- PubMed-indexed human/clinical literature: PMID 17913231.
- Current merchant/product materials supplied for this project, reviewed August 21, . Product formulation, prices, bonuses and guarantee statements are treated as merchant representations rather than independent efficacy evidence.
References are included for research context. Evidence on a constituent ingredient does not automatically validate the finished product.
Current merchant offer
Compare the current Nitric Boost Ultra package options.
The supplied merchant materials reviewed August 21, show one-, three- and six-jar packages. Commercial terms can change; verify the live checkout before purchasing.
1 Jar · 30 Days
$69 total · $69/jar
Shipping additional in the supplied offer.
6 Jars · 180 Days
$294 total · $49/jar
Free U.S. shipping + two digital bonuses currently displayed.
3 Jars · 90 Days
$177 total · $59/jar
Free U.S. shipping + two digital bonuses currently displayed.
Continue the research
Explore the Nitric Boost Ultra evidence cluster.
Safety & mechanism
Ingredient deep dives
L-Arginine →
L-Citrulline →
Beet Root →
D-Aspartic Acid →
Horny Goat Weed →